Anticancer traits of chimeric antigen receptors (CARs)-Natural Killer (NK) cells as novel approaches for melanoma treatment

Owing to non-responsiveness of a high number of patients to the common melanoma therapies, seeking novel approaches seem as an unmet requirement. Chimeric antigen receptor (CAR) T cells were initially employed against recurrent or refractory B cell malignancies. However, advanced stages or pretreate...

Descripción completa

Detalles Bibliográficos
Autores principales: Bahmanyar, Maryam, Vakil, Mohammad Kazem, Al-Awsi, Ghaidaa Raheem Lateef, Kouhpayeh, Seyed Amin, Mansoori, Yaser, Mansoori, Behnam, Moravej, Ali, Mazarzaei, Abdulbaset, Ghasemian, Abdolmajid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701052/
https://www.ncbi.nlm.nih.gov/pubmed/36434591
http://dx.doi.org/10.1186/s12885-022-10320-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701052/
https://www.ncbi.nlm.nih.gov/pubmed/36434591
http://dx.doi.org/10.1186/s12885-022-10320-0

Ejemplares similares